Diagnosing Sarcoidosis: A Three-Pillar Approach
The diagnosis of sarcoidosis requires three essential criteria: (1) a compatible clinical and radiologic presentation, (2) histopathologic evidence of nonnecrotizing granulomas (with specific exceptions), and (3) exclusion of alternative causes of granulomatous disease—recognizing that this diagnosis is never fully secure. 1
Clinical Presentation Assessment
Start by identifying whether the patient exhibits presentations that are highly supportive or merely consistent with sarcoidosis 1:
Highly Supportive Presentations (May Not Require Biopsy)
- Löfgren's syndrome: Bilateral hilar adenopathy + erythema nodosum and/or periarticular arthritis
- Lupus pernio: Chronic violaceous skin lesions on nose, cheeks, ears
- Heerfordt's syndrome: Fever, parotid enlargement, anterior uveitis, facial nerve palsy
- Asymptomatic bilateral hilar adenopathy on imaging
For these highly supportive presentations, lymph node sampling is NOT recommended 1. These patients require close clinical follow-up instead, as the diagnosis can be made clinically without tissue confirmation.
Presentations Consistent With Sarcoidosis
Look for these specific features 1:
Pulmonary/Thoracic:
- Bilateral hilar lymphadenopathy on chest imaging
- Interstitial lung disease patterns
- Persistent dry cough and dyspnea in young to middle-aged adults
Extrapulmonary:
- Anterior or posterior uveitis
- Peripheral lymphadenopathy
- Skin nodules, plaques, or papules (excluding erythema nodosum)
- New-onset third-degree AV block in young/middle-aged adults
- Reduced left ventricular ejection fraction without traditional risk factors
- Nephrolithiasis with calcium stones
- Elevated alkaline phosphatase (>3× upper limit of normal)
- Inflammatory lesions in bone on imaging
- Hepatosplenomegaly with nodules
Histopathologic Confirmation
When clinical presentation is not highly supportive, obtain tissue biopsy showing nonnecrotizing granulomas 1.
Key Pathologic Features Favoring Sarcoidosis 1:
- Granuloma morphology: Compact, tightly formed collections of epithelioid histiocytes and multinucleated giant cells
- Distribution: Perilymphatic pattern (around bronchovascular bundles, pleura)
- Necrosis: Absent or only minimal focal ischemic necrosis
- Surrounding inflammation: Sparse lymphocytic infiltrate
- Microorganism stains: Negative
Features AGAINST Sarcoidosis 1:
- Extensive or "dirty" necrosis with nuclear debris
- Palisading granulomas
- Positive microorganism stains or cultures
- Robust inflammatory infiltrate with neutrophils, eosinophils, plasma cells
Biopsy Site Selection:
Choose the most accessible site first:
- Skin lesions or peripheral lymph nodes (if present)
- Bronchoscopy with transbronchial biopsy for lung involvement
- Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for mediastinal/hilar lymph nodes—this has replaced mediastinoscopy with high diagnostic yield 2
Exclusion of Alternative Diagnoses
You must actively exclude these mimickers 1:
Infections to Rule Out:
- Mycobacterial disease (tuberculosis, atypical mycobacteria): Obtain AFB stains, cultures, and consider tuberculin skin test or interferon-gamma release assay
- Fungal infections (histoplasmosis, coccidioidomycosis, blastomycosis): Fungal stains and cultures
- Berylliosis: Occupational history and beryllium lymphocyte proliferation test if exposure suspected
Other Granulomatous Diseases:
- Hypersensitivity pneumonitis: Detailed environmental/occupational exposure history
- Granulomatosis with polyangiitis: Check ANCA (MPO/PR3 antibodies)
- IgG4-related disease: Serum IgG4 levels and IgG4:IgG ratio; IgG4 immunostaining on biopsy
- Common variable immunodeficiency: Immunoglobulin levels
- Malignancy with sarcoid-like reaction: Particularly in patients with known or suspected cancer
- Drug-induced granulomatous disease: Review medication history (immune checkpoint inhibitors, TNF-alpha inhibitors)
Diagnostic Algorithm
Follow this stepwise approach 1:
Assess clinical presentation → Is it highly supportive (Löfgren's, lupus pernio, Heerfordt's, asymptomatic BHA)?
- YES → Skip biopsy, proceed to baseline testing, close follow-up
- NO → Continue to step 2
Is presentation consistent with sarcoidosis? (See features above)
- YES → Proceed to step 3
- NO → Consider alternative diagnosis
Obtain tissue biopsy from most accessible site showing nonnecrotizing granulomas
- Positive and consistent → Proceed to step 4
- Negative or inconsistent → Reconsider diagnosis
Exclude alternative causes (infections, other granulomatous diseases)
- Excluded → Diagnosis: Probable sarcoidosis
- Not excluded → Treat alternative diagnosis
Critical Pitfalls to Avoid
The presence of granulomas alone does NOT establish sarcoidosis—you must exclude infections and other causes 2. In tuberculosis-endemic regions or patients from such areas, distinguishing sarcoidosis from TB is particularly challenging and may require empirical anti-TB treatment trials if diagnostic uncertainty persists 3.
Asymptomatic bilateral hilar adenopathy is almost always sarcoidosis in the appropriate clinical context, making invasive testing often unnecessary 1.
The diagnosis is never fully secure—sarcoidosis remains a diagnosis of exclusion, and clinical vigilance for alternative diagnoses must continue even after initial diagnosis 1.